1.alpha Amylase
1.alpha Amylase
1.alpha Amylase
COMPOSITION
REFERENCE VALUES
REAGENT A:
CNP-G3 2 mmol/l
Serum or plasma up to 90 U/l
Sodium chloride 250 mmol/l
Urine up to 480 U/l
Calcium chloride 6 mmol/l
MES buffer 100 mmol/l
Each laboratory should establish reference ranges for its
Potassium thiocyanate 600 mmol/l
own patients population.
Sodium azide < 0.1%
Preparation:
ANALYTICAL PERFORMANCES
The reagent is liquid ready to use. Precision
Within-run and between-run coefficients of variation have
Storage and stability been calculated on replicates of three samples at different
Store at 2-8 °C. Do not freeze the reagents! The reagents enzymatic activities. The obtained results are reported in
are stable until the expiry date, if contamination and the following tables:
evaporation are avoided, protected from light. The above
conditions are valid if the vials are opened just only for the Within Run Between Run
time to take the reagent, closed immediately with their cap Mean
Sample SD %CV SD %CV
and stored at the indicated conservation temperature. (U/l)
Serum 1 72.50 0.92 1.3 1.74 2.4
Saliva and skin contain Amylase: never pipette by mouth
Serum 2 124.80 1.19 1.0 4.94 4.0
and avoid skin contact with reagents.
Serum 3 175.32 1.74 1.0 6.13 3.5
ANCILLARY EQUIPMENT
Automatic pipettes Linearity
Photometer The assay is linear up to 1500 U/l.
Analysis cuvettes (optical path = 1 cm)
Temperature controlled water bath Sensitivity
NaCl solution 9 g/l Test sensitivity, in terms of limit of detection, is 3 U/l.
SAMPLES Correlation
Serum, heparin plasma and urine. A correlation study comparing the present method an a
Stable 7 days at 2-8 °C or 30 days at -20 °C. commercial one gave the following results:
Pag. 1/2
GA4175 00 - KL4175 00 - BK4175 00 Alpha AMYLASE
PRECAUTIONS IN USE
The Reagent A (REF GB017500) is not considered
harmful (GHS00) according to (CE) n. 1272/2008
directive about classification, packaging and labelling of
dangerous substances.
Reagent A:
Supplemental Hazard statement Codes:
EUH032 - Contact with acids liberates very toxic gas.
EUH210 - Safety data sheet available on request.
However, the reagents should be handled with caution,
avoiding swallowing and contact with skin, eyes and
mucous membranes.
The use of laboratory reagents according to good laboratory
practice is recommended.
Waste Management
Please refer to local legal requirements.
BIBLIOGRAPHY
1. Lorentz K. -Amylase. In: Thomas L, editor. Clinical
laboratory diagnostics. 1st ed. Frankfurt: TH-Books
Verlagsgesellschaft; 1998, p. 192-202.
2. Tietz N W (ed): Clinical guide to laboratory tests, 3rd
reprint. Philadelphia, PA: WB Saunders Company;
1995:46-49.
3. Jakobs DS, Kasten Jr. BL, Demmott WR, Wolfson WL:
“Laboratory Test Handbook”, Lexi-Comp and Williams &
Wilkins Ed. 2nd Edition (1990).
4. International Federation of Clinical Chemistry and
Laboratory Medicine (IFCC): “Approved
Recommendation on IFCC Methods for the
measurement of catalytic concentration of enzymes –
Part 9. IFCC Method for -Amylase (1,4--D-Glucan 4-
Glucanohydrolase, EC 3.2.1.1)” – Clin Chem Lab Med
1998; 36(3):185-203.
5. EU-Dir 1999/11 Commission Directive of 8 March 1999
adapting to technical progress the principles of good
laboratory practice as specified in Council Directive
87/18/EEC.
6. NCCLS Document, “Procedures for the collection of
arterial blood specimens”, Approved Standard, 3rd Ed.
(1999).
Pag. 2/2